Journal: Nature Cell Biology
Article Title: Sphingolipid subtypes differentially control proinsulin processing and systemic glucose homeostasis
doi: 10.1038/s41556-022-01027-2
Figure Lengend Snippet: a , Experimental setup for identification of SBPs in a SILAC-based approach. pacSph treatment of Sgpl1 ΔIns1E and CerS2:Sgpl1 ΔIns1E cells differentially labelled with stable isotopes allows crosslinking of SL-protein complexes by UV irradiation (with omission of UV irradiation as a control condition), followed by cell lysis and conjugation of biotin to the SL-protein complexes. After Streptavidin-based pull-down, SBPs can be identified and quantified in the same MS run by the differing peptide mass due to SILAC isotope labelling. b , Volcano plot showing log 2 fold change of proteins pulled down from pacSph-treated Sgpl1 ΔIns1E (+UV) versus Sgpl1 ΔIns1E (−UV) cells plotted against the −log 10 P values of a one-sample two-sided t -test against 0. Proteins with log 2 fold change >1 and a BH-FDR <0.05 are regarded as SBPs ( n = 4 independent experiments). c , Volcano plot showing log 2 fold change of SBPs identified in b (Supplementary Fig. ) and pulled down from pacSph-treated CerS2:Sgpl1 ΔIns1E (+UV) versus Sgpl1 ΔIns1E (+UV) cells plotted against the −log 10 P values of a two-sample two-sided equal variance t -test ( n = 4 independent experiments). SBPs with a fold change >1.5 and a BH-FDR <0.05 were regarded as Cers2-dependent SBPs. Fold enrichment was 6.55 and FDR-corrected P value was 3.12 −10 for GO term ‘endoplasmic reticulum’. d , pacSph pull-down of endogenous Tmed2 in Sgpl ΔIns1E and Sgpl1:CerS2 ΔIns1E cells ( n = 4 independent experiments); exemplary immunoblot (right) and quantification (left). Eluate intensities were normalized to respective input intensities. e , Relative mRNA expression of Tmed1, Tmed2 and Pcsk1 in murine pseudoislets transfected with control siRNA or siRNA against Tmed1, Tmed2 or both. n = 4 independent experiments. f – i , Immunoblot detection of Pro-Pcsk1 and Pcsk1 protein levels in pseudoislets transfected with siRNA as described in Extended Data Fig. ; n = 3 independent experiments. f , Representative immunoblot. g , Quantification of Pcsk1. h , Quantification of Pro-Pcsk1. i , Ratio of Pcsk1 to Pro-Pcsk1. j – l , Insulin content ( j ), proinsulin content ( k ) and ratio of insulin to proinsulin ( l ) in pseudoislets transfected with siRNA as described in Extended Data Fig. determined via ELISA ( n = 8 independent experiments). Statistical analyses were performed using one-way ANOVA with Tukey’s multiple comparisons test ( d ) and repeated measures one-way ANOVA with Tukey’s multiple comparisons test ( e and g – l ). In e , ANOVA was performed for each mRNA target individually. P values are stated in each figure. Data points in d , e and g – l represent individual experiments. Bar graphs represent mean ± s.e.m. For one experiment in j – l , the mean of five replicates, consisting of nine pseudoislets, respectively, was plotted per condition. Stain-free signal was used for normalization of immunoblots in g – i . Source numerical data and unprocessed blots are available in source data.
Article Snippet: To determine overlap of Tmed2 and Pcsk1 with ER and Golgi, we used the following plasmids: Tmed2-Myc-DDK (Origene, #RC206849), Pcsk1-Myc-DDK (DDK-tag will be cleaved off during maturation into enzymatically active Pcsk1; Origene, #MR225451) and the Pro-/Pcsk1-DDK plasmid described above.
Techniques: Irradiation, Lysis, Conjugation Assay, Western Blot, Expressing, Transfection, Enzyme-linked Immunosorbent Assay, Staining